Pictured left: Jussi Taipale, Sakari Vanharanta, Lauri Aaltonen and Carl de Boer. Photo: Sakari Vanharanta

iCAN Executive Committee Members Awarded €10 Million ERC Synergy Grant for Groundbreaking Genome Research

wo members of the iCAN Executive Committee, Professor Sakari Vanharanta and Professor Lauri Aaltonen, are among the leading researchers behind a major international research initiative that has been awarded approximately €10 million in European Research Council (ERC) Synergy Grant funding.

The six-year project, FIBERMAP, brings together researchers from the University of Helsinki, the Wellcome Sanger Institute in the United Kingdom and the University of British Columbia in Canada. The consortium is led by Sakari Vanharanta, Lauri Aaltonen, Jussi Taipale and Carl de Boer. Approximately €4.5 million of the total funding will support research at the University of Helsinki.

FIBERMAP aims to advance understanding of how the human genome is regulated in healthy tissues and tumours. While the human genome has been sequenced, much remains to be understood about the regulatory mechanisms that determine when and where genes are activated. These mechanisms play a critical role in health and disease, including cancer development.

Combining advanced DNA technologies, molecular profiling, computational biology and machine learning, the project will investigate genome regulation at an unprecedented level of detail. Researchers will focus on colorectal cancer, kidney cancer and uterine leiomyoma, generating new insights into how genetic and epigenetic changes influence cellular behaviour and disease development.

The research has the potential to improve the interpretation of individual genomes, deepen understanding of disease mechanisms and contribute to the development of earlier diagnostics and more precise treatments.

The ERC Synergy Grant is one of Europe’s most competitive research funding schemes, recognising outstanding research teams whose complementary expertise enables them to address complex scientific challenges.

iCAN congratulates Sakari Vanharanta, Lauri Aaltonen and their international collaborators on this outstanding achievement. Their success reflects the strength of cancer research at the University of Helsinki and the importance of international scientific collaboration in advancing our understanding of cancer and human health.

We are proud to see two members of our Executive Committee contributing to research that pushes the boundaries of genomic science and opens new possibilities for future healthcare.

iCAN is part of the Research Council of Finland Flagship Programme with the University of Helsinki and HUS Helsinki University Hospital as founding partners.

Please get in touch:

ican@helsinki.fi

Follow us on social media:

© 2026 iCAN – Privacy Policy